Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02387658 · ClinicalTrials.gov registry record
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
A clinical trial, sponsored by North Texas Veterans Healthcare System.
- Completed
- Registry status
- 25
- Enrollment target
NCT02387658 is a clinical trial that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 25 participants.
The verdict
NCT02387658 has completed, sponsored by North Texas Veterans Healthcare System.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
1. To perform an observational analysis to determine if mean translesional gradient measurements (TLG) are associated with differences in clinical outcomes in patients with femoropopliteal arterial disease and claudication. 2. Hypothesis: Patients stratified by a residual translesional gradient \</= 11 mmHg after peripheral revascularization or angiography alone will have better clinical outcomes than patients with TLG \> 11 mmHg as assessed by six minute walk (6MW), walking impairment questionnaire scores (WIQ), ankle brachial index and need for repeat procedure at 6 months.
Interventions
- PROCEDURE translesional gradient measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-02-06 |
| Est. Completion | 2016-07-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02387658
The ClinicalTrials.gov registry entry for NCT02387658 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Texas Veterans Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which translesional gradient measurement is the first listed.
NCT02387658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02387658 about?
NCT02387658 is a clinical study titled "Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient". 1. To perform an observational analysis to determine if mean translesional gradient measurements (TLG) are associated with differences in clinical outcomes in patients with femoropopliteal arterial disease and claudication. 2. Hypothesis: Patients stratified by a residual translesional gradient \</=...
What is the current status of trial NCT02387658?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-02-06. Estimated completion is 2016-07-13.
What interventions are being tested in trial NCT02387658?
The interventions under investigation include: translesional gradient measurement (PROCEDURE).
Who is sponsoring clinical trial NCT02387658?
This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.